Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer - Saga, Tsuneo; Inubushi, Masayuki; Koizumi, Mitsuru; Yoshikawa, Kyosan; Zhang, Ming-Rong; Tanimoto, Katsuyuki; Horiike, Atsushi; Yanagitani, Noriko; Ohyanagi, Fumiyoshi; Nishio, Makoto (Cancer science, 2015)
Keywords: Adult; Aged; Carcinoma, Non-Small-Cell Lung - diagnostic imaging; Carcinoma, Non-Small-Cell Lung - mortality; Disease-Free Survival; Female; Fluorodeoxyglucose F18 - pharmacology; Humans; Kaplan-Meier Estimate; Lung Neoplasms - diagnostic imaging; Lung Neoplasms - mortality; Male; Middle Aged; Multimodal Imaging - methods; Nitroimidazoles - pharmacology; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals - pharmacology; Tomography, X-Ray Computed; 18F-fluorodeoxyglucose (FDG); positron emission tomography/computed tomography (PET/CT); prognosis; 18F-fluoroazomycin arabinoside (FAZA); non-small-cell lung cancer